A Long-term Follow-up of the HIV-NAT Cohort

Recruiting Observational Study
HIV Infections
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
The HIV Netherlands Australia Thailand Research Collaboration · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
With HIV/AIDS increasingly considered a chronic disease, 24-, or 48-week data from antiretroviral studies are no longer sufficient. Only with long-term follow-up and outcome data will shed some much-needed light on the answers of questions that have stumped us for several years. Data from a large observational cohort of patients treated with combination antiretroviral therapy will provide further …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * HIV infected patients( children and adults) previously participated HIV-NAT studies * HIV infected patients( children and adults) currently participate in HIV-NAT trials * Able to provide written consent Exclusion Criteria: * Unable to provide written consent
Contacts

Anchalee Avihingsanon, MD, PhD

66 2 2557334-5

anchalee.a@hivnat.org

CONTACT

Stephen Kerr, PhD

66 2 2557334-5

s.kerr@unsw.edu.au

CONTACT